The role of noradrenaline and selective noradrenaline reuptake inhibition in depression.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  European Neuropsychopharmacology

• Publication date

  2002-10-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/S0924-977X(02)00057-3PMID 12208564
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Reboxetine, a New Noradrenaline Selective Antidepressant, Is at Least as Effective as Fluoxetine in the Treatment of Depression

  2002cited by this paper
• Reboxetine, a selective norepinephrine reuptake inhibitor, is an effective and well-tolerated treatment for panic disorder.

  2002cited by this paper
• Reboxetine: a pharmacologically potent, selective, and specific norepinephrine reuptake inhibitor.

  2000cited by this paper
• Double-blind, placebo-controlled study with reboxetine in inpatients with severe major depressive disorder.

  2000cited by this paper
• Social functioning in depression: a review.

  2000cited by this paper
• Assessment of social functioning in depression.

  2000cited by this paper
• Reboxetine, a unique selective NRI, prevents relapse and recurrence in long-term treatment of major depressive disorder.

  1999cited by this paper
• Is severe depression a separate indication? ECNP Consensus Meeting September 20, 1996, Amsterdam. European College of Neuropsychopharmacology.

  1999cited by this paper
• Analysis and metaanalysis of two polymorphisms within the tyrosine hydroxylase gene in bipolar and unipolar affective disorders.

  1999cited by this paper
• Reboxetine: a double-blind comparison with fluoxetine in major depressive disorder.

  1999cited by this paper
• From symptoms to social functioning: differential effects of antidepressant therapy.

  1999cited by this paper
• Antidepressant Therapy at the Dawn of the Third Millennium

  1999cited by this paper
• Reboxetine versus imipramine in the treatment of elderly patients with depressive disorders: a double-blind randomised trial.

  1999cited by this paper
• Physiology to functionality: the brain and neurotransmitter activity.

  1999cited by this paper
• Is severe depression a separate indication? ECNP Consensus Meeting September 20, 1996, Amsterdam. European College of Neuropsychopharmacology.

  1999cited by this paper
• Antidepressants and the brain.

  1999cited by this paper
• Predicting response: serotonin reuptake inhibition.

  1999cited by this paper
• Antidepressant effectiveness in severe depression and melancholia.

  1999cited by this paper
• Reboxetine versus fluoxetine: an overview of efficacy and tolerability.

  1998cited by this paper
• Mirtazapine: efficacy and tolerability in comparison with fluoxetine in patients with moderate to severe major depressive disorder. Mirtazapine-Fluoxetine Study Group.

  1998cited by this paper
• Effects of tryptophan depletion in drug-free depressed patients who responded to total sleep deprivation.

  1998cited by this paper
• Clinical efficacy of reboxetine: a comparative study with desipramine, with methodological considerations

  1998cited by this paper
• Selective Increase of α2A‐Adrenoceptor Agonist Binding Sites in Brains of Depressed Suicide Victims

  1998cited by this paper
• Noradrenaline in basic models of depression.

  1997cited by this paper
• Antidepressants.

  1997cited by this paper
• Genetic association between monoamine oxidase and manic-depressive illness: comparison of relative risk and haplotype relative risk data.

  1997cited by this paper
• Depression : neurobiological, psychopathological, and therapeutic advances

  1997cited by this paper
• Reboxetine: a review of antidepressant tolerability.

  1997cited by this paper
• Relapse of depression after rapid depletion of tryptophan.

  1997cited by this paper
• Efficacy and tolerability of reboxetine compared with imipramine in a double-blind study in patients suffering from major depressive episodes

  1997cited by this paper
• The epidemiology of DSM-III-R bipolar I disorder in a general population survey

  1997cited by this paper
• Efficacy and tolerability of reboxetine compared with imipramine in a double-blind study in patients suffering from major depressive offsodes.

  1997cited by this paper
• Noradrenaline-selective versus serotonin-selective antidepressant therapy: differential effects on social functioning.

  1997cited by this paper
• Mixed depression and anxiety: serotonin1A receptors as a common pharmacologic link.

  1997cited by this paper
• The role of noradrenaline in depression: a review.

  1997cited by this paper
• A Risk-Benefit Assessment of Mirtazapine in the Treatment of Depression

  1997cited by this paper
• Depression in the community: the first pan‐European study DEPRES (Depression Research in European Society)

  1997cited by this paper
• Development and validation of a social functioning scale, the Social Adaptation Self-evaluation Scale.

  1997cited by this paper
• Reboxetine: additional benefits to the depressed patient.

  1997cited by this paper
• Catechol-O-methyltransferase Val158Met polymorphism: frequency analysis in Han Chinese subjects and allelic association of the low activity allele with bipolar affective disorder.

  1997cited by this paper
• Association analysis of the catechol O-methyltransferase gene and bipolar affective disorder.

  1997cited by this paper
• Clinical and biochemical effects of catecholamine depletion on antidepressant-induced remission of depression.

  1996cited by this paper
• Patterns of Antidepressant Use and Their Relation to Costs of Care

  1996cited by this paper
• Milnacipran and selective serotonin reuptake inhibitors in major depression

  1996cited by this paper
• Genetic association between monoamine oxidase A microsatellite and RFLP alleles and bipolar affective disorder: analysis and meta-analysis.

  1996cited by this paper
• TREATMENT OF MAJOR DEPRESSION IN GENERAL PRACTICE: A DOUBLE‐BLIND COMPARISON OF PAROXETINE AND LOFEPRAMINE

  1996cited by this paper
• A double-blind comparison of venlafaxine and fluoxetine for treatment of major depression in outpatients.

  1996cited by this paper
• Comparison of compliance between serotonin reuptake inhibitors and tricyclic antidepressants: a meta‐analysis

  1995cited by this paper
• Evidence for a genetic association between alleles of monoamine oxidase A gene and bipolar affective disorder.

  1995cited by this paper
• Effectiveness of venlafaxine in patients hospitalized for major depression and melancholia.

  1995cited by this paper
• Manic-depression and the norepinephrine transporter gene.

  1995cited by this paper
• A double-blind controlled comparison of fluoxetine and lofepramine in major depressive illness

  1994cited by this paper
• Antidepressant drug selection: criteria and options.

  1994cited by this paper
• Binding of antidepressants to human brain receptors: focus on newer generation compounds

  1994cited by this paper
• Serotonin and the neurobiology of depression. Effects of tryptophan depletion in drug-free depressed patients.

  1994cited by this paper
• A double‐blind comparison of venlafaxine and fluoxetine in patients hospitalized for major depression and melancholia

  1994cited by this paper
• Life-time risk of depression

  1994cited by this paper
• Up-regulation of β1-adrenergic receptors in rat brain after chronic citalopram and fluoxetine treatments

  1994cited by this paper
• Fluoxetine efficacy in treatment resistant depression.

  1994cited by this paper
• Defining Melancholia: Properties of a Refined Sign-Based Measure

  1994cited by this paper
• Lifetime Risk of Depression

  1994cited by this paper
• A linkage study with D5 dopamine and α2C‐adrenergic receptor genes in six multiplex bipolar pedigrees

  1994cited by this paper
• A double-blind comparison of sertraline and nortriptyline in the treatment of depressed geriatric outpatients

  1994cited by this paper
• Venlafaxine for treatment-resistant unipolar depression.

  1994cited by this paper
• Exclusion of close linkage of bipolar disorder to the Gs-alpha subunit gene in nine Australian pedigrees.

  1994cited by this paper
• Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey.

  1994cited by this paper
• Brofaromine in treatment-resistant depressed patients--a comparative trial versus tranylcypromine.

  1994cited by this paper
• Comparative efficacy of selective serotonin reuptake inhibitors and tricyclics in the treatment of melancholia.

  1994cited by this paper
• Selective serotonin reuptake inhibitors: meta‐analysis of discontinuation rates

  1994cited by this paper
• The efficacy of selective serotonin re-uptake inhibitors in depression: a meta-analysis of studies against tricyclic antidepressants

  1994cited by this paper
• A double-blind crossover trial of imipramine and phenelzine for outpatients with treatment-refractory depression.

  1993cited by this paper
• Fluoxetine and desipramine in major depressive disorder.

  1993cited by this paper
• Blockade by newly-developed antidepressants of biogenic amine uptake into rat brain synaptosomes.

  1993cited by this paper
• Preliminary report: placebo-controlled, double-blind study of the clinical and metabolic effects of desipramine in panic disorder.

  1993cited by this paper
• The costs of depression

  1993cited by this paper
• Moclobemide: a reversible MAO-A-inhibitor showing weaker antidepressant effect than clomipramine in a controlled multicenter study. Danish University Antidepressant Group.

  1993cited by this paper
• Depression-related impairment: estimating concurrent and lingering effects

  1993cited by this paper
• The economic burden of depression in 1990.

  1993cited by this paper
• The Galway Study of Panic Disorder. I: Clomipramine and lofepramine in DSM III-R panic disorder: a placebo controlled trial.

  1992cited by this paper
• Treatment of imipramine-resistant recurrent depression, III: Efficacy of monoamine oxidase inhibitors.

  1992cited by this paper
• CLOMIPRAMINE AND LOFEPRAMINE IN DSM III‐R PANIC DISORDER: A PLACEBO CONTROLLED TRIAL.

  1992cited by this paper
• α2-Adrenoceptors in the brain of suicide victims: increased receptor density associated with major depression

  1992cited by this paper
• Randomized Double-Blind Study of Fluvoxamine and Maprotiline in Treatment of Depression

  1991cited by this paper
• Comparative efficacy and safety of nortriptyline and fluoxetine in the treatment of major depression: a clinical study.

  1991cited by this paper
• Selective Serotonin Re-Uptake Inhibitors: The Clinical Use of Citalopram, Fluoxetine, Fluvoxamine, Paroxetine, and Sertraline

  1991cited by this paper
• Comparative efficacy and safety of nortriptyline and fluoxetine in the treatment of major depression: a clinical study.

  1991cited by this paper
• Desipramine treatment in panic disorder.

  1991cited by this paper
• Brain beta-adrenoceptor binding sites in antidepressant-free depressed suicide victims.

  1990cited by this paper
• Fluvoxamine in the treatment of tricyclic-resistant depression.

  1990cited by this paper
• A double-blind comparison of fluvoxamine, desipramine and placebo in outpatients with depression.

  1990cited by this paper
• Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan.

  1990cited by this paper
• Fluoxetine 40 mg vs maprotiline 75 mg in the treatment of out-patients with depressive disorders.

  1989cited by this paper
• Sex‐related differences in central adrenergic function and responsiveness to repeated administration of desipramine or electroconvulsive shock

  1989cited by this paper
• The functioning and well-being of depressed patients. Results from the Medical Outcomes Study.

  1989cited by this paper
• Rechutes de dépression unipolaire et efficacité de la maprotiline

  1989cited by this paper
• Efficacy of fluvoxamine in treatment-refractory depression.

  1988cited by this paper
• Cardiovascular Effects of Antidepressant Medications

  1988cited by this paper
• Treatment of panic and phobic disorders.

  1987cited by this paper
• Modifications of the Serotonin System by Antidepressant Treatments: Implications for the Therapeutic Response in Major Depression

  1987cited by this paper
• Independent regulation of β1‐ and β2‐adrenoceptors

  1987cited by this paper

• Reboxetine Treatment Reduces Hippocampal Gliosis in the P301S Tauopathy Mouse Model.

  2026cites this paper
• Environmental behavior, risks, and management of antidepressants in the aquatic environment.

  2025cites this paper
• Herbal Cannabis and Depression: A Review of Findings Published over the Last Three Years

  2024cites this paper
• Pharmacological Investigation of Pithecellobium dulce Stem Bark extract for Anti-Depressant Activity on Mice and Rats

  2024cites this paper
• Real-world characteristics of European patients receiving SNRIs as first-line treatment for major depressive disorder.

  2023cites this paper
• Utility of pharmacogenetic testing to optimise antidepressant pharmacotherapy in youth: a narrative literature review

  2023cites this paper
• Effect of Moringa oleifera Leaf Extracts on Depression in Rheumatoid Arthritis Patients

  2023cites this paper
• Antidepressant and Anxiolytic Effects of L-Methionine in the WAG/Rij Rat Model of Depression Comorbid with Absence Epilepsy

  2023cites this paper
• Investigation of non-invasive focused ultrasound efficacy on depressive-like behavior in hemiparkinsonian rats

  2023cites this paper
• Estrogenic active Ecklonia cava extract improves bone loss and depressive behaviour in OVX mice

  2023cites this paper
• Antidepressant-like Effects of Representative Types of Food and Their Possible Mechanisms

  2023cites this paper
• From pupil to the brain: New insights for studying cortical plasticity through pupillometry

  2023cites this paper
• Fermented Wheat Germ Alleviates Depression-like Behavior in Rats with Chronic and Unpredictable Mild Stress

  2023cites this paper
• The antidepressant effect of tramadol and chlorpheniramine combination in mice model

  2023cites this paper
• Etiopathogenesis of depression and experimental depression models used in preclinical studies

  2023cites this paper
• Noradrenergic neuromodulation in ageing and disease.

  2023cites this paper
• Longitudinal evaluations of somatosensory-motor inhibition in Dopa-responsive dystonia.

  2022cites this paper
• Chronic adolescent stress increases exploratory behavior but does not change the acute stress response in adult male C57BL/6 mice

  2021cites this paper
• INVOLVEMENT OF MONOAMINERGIC SYSTEM IN THE ANTIDEPRESSANT-LIKE EFFECT OF Ocimum sanctum (LINN.) LEAVES EXTRACT IN TAIL SUSPENSION TEST IN MICE

  2021cites this paper
• A Crab Is Not a Fish: Unique Aspects of the Crustacean Endocrine System and Considerations for Endocrine Toxicology

  2021cites this paper
• Between Temperament and Psychopathology: Examples from Neuropharmacological Challenge Tests in Healthy Humans

  2021cites this paper
• Solubility, thermodynamic properties, Hansen solubility parameter, and molecular simulation of amitriptyline hydrochloride (Form I) in fourteen organic pure solvents at different temperatures

  2021cites this paper
• The Application of a Machine Learning-Based Brain Magnetic Resonance Imaging Approach in Major Depression.

  2021cites this paper
• Glycogen Synthase Kinase-3: A Focal Point for Advancing Pathogenic Inflammation in Depression

  2021cites this paper
• Chronic adolescent stress increases exploratory behavior but does not appear to change the acute stress response in adult male C57BL/6 mice

  2021cites this paper
• Antidepressant Screening Demonstrated Non-Monotonic Responses to Amitriptyline, Amoxapine and Sertraline in Locomotor Activity Assay in Larval Zebrafish

  2021cites this paper
• Neuromodulatory effect of curcumin on catecholamine systems and inflammatory cytokines in ovariectomized female rats

  2020cites this paper
• DETECTION OF ANTIDEPRESSANT EFFECT OF ALCOHOLIC EXTRACT OF ALHAGI MAURORUM MEDIK ON MICE

  2020cites this paper
• Effects of EGCG on depression-related behavior and serotonin concentration in a rat model of chronic unpredictable mild stress.

  2020cites this paper
• Involvement of Glutamate and Serotonin Transmitter Systems in Male Sex Determination in Daphnia pulex.

  2020cites this paper
• Antidepressant Activity of Alpha-lactalbumin in Chronic Unpredictable Stress Model in Swiss Albino Mice

  2020cites this paper
• Revisiting the Concept of Human Disease

  2020cites this paper
• Antidepressant effect of Gentiana olivieri Griseb. in male rats exposed to chronic mild stress

  2020cites this paper
• The Antidepressant-Like Effects of Menthol through Dopaminergic System Using Forced Swimming Test in a Mice Model

  2019cites this paper
• The Antidepressant-Like Effects of Menthol Via Dopaminergic System Using Forced Swimming Test in a Mice Model

  2019cites this paper
• Evaluation of Antidepressant Activity of Ethanolic Extract of Abies webbiana and Berberis aristata in Laboratory Animals

  2019cites this paper
• Pharmacological In vivo test to evaluate the antidepressant activity of polyherbal formulation

  2019cites this paper
• Biogenic Amine Transmitters

  2019cites this paper
• Biogenic Amine Transmitters: Acetylcholine, Norepinephrine, and Dopamine

  2019cites this paper
• Contribution of skeletal muscular glycine to rapid antidepressant effects of ketamine in an inflammation-induced mouse model of depression

  2019cites this paper
• Increased thioredoxin‐interacting protein in brain of mice exposed to chronic stress

  2019cites this paper
• Pathophysiology of Depression: Molecular Regulation of Melatonin Homeostasis – Current Status

  2018cites this paper
• Subchronic administration of creatine produces antidepressant-like effect by modulating hippocampal signaling pathway mediated by FNDC5/BDNF/Akt in mice.

  2018cites this paper
• Synthesis and biological evaluation of magnolol derivatives as melatonergic receptor agonists with potential use in depression.

  2018cites this paper
• Antidepressant and pro‐neurogenic effects of agmatine in a mouse model of stress induced by chronic exposure to corticosterone

  2018cites this paper
• T-type calcium channel enhancer SAK3 promotes dopamine and serotonin releases in the hippocampus in naive and amyloid precursor protein knock-in mice

  2018cites this paper
• Correction: T-type calcium channel enhancer SAK3 promotes dopamine and serotonin releases in the hippocampus in naive and amyloid precursor protein knock-in mice

  2018cites this paper
• The effect of electroconvulsive therapy on the levels of oxidative stress factors in the prefrontal cortex of depressed rats

  2018cites this paper
• A study on antidepressant-like effect of dihydroxy flavones in mice and their mechanisms involved

  2018cites this paper
• Involvement of the monoaminergic system in the antidepressant-like effect of the crude extract of Mentha piperita (Lamiaceae) in the forced swimming test in mice

  2017cites this paper
• The recent progress in animal models of depression

  2017cites this paper
• Antidepressant-like deliverables from the sea: evidence on the efficacy of three different brown seaweeds via involvement of monoaminergic system

  2017cites this paper
• Effects of phenolic constituents of daylily flowers on corticosterone- and glutamate-treated PC12 cells

  2017cites this paper
• Hiponutrición perinatal y depresión: estudio de la reversión de las conductas depresivas facilitadas por la injuria nutricional temprana.

  2017cites this paper
• 22‐azidosalvinorin A exhibits antidepressant‐like effect in mice

  2017cites this paper
• Molecular Mechanisms Underlying the Anti-depressant Effects of Resveratrol: a Review

  2017cites this paper
• Chirality of Modern Antidepressants: An Overview

  2017cites this paper
• Inhibition of the norepinephrine transporter by χ‐conotoxin dendrimers

  2016cites this paper
• A study of the action of risperidone at 5-HT2A receptors

  2016cites this paper
• Antidepressant therapies inhibit inflammation and microglial M1-polarization.

  2016cites this paper
• THE DEVELOPMENT OF DEPRESSION AS A DYSFUNCTION OF THE IMMUNE SYSTEM.

  2016cites this paper
• Involvement of adrenoceptors, dopamine receptors and AMPA receptors in antidepressant-like action of 7-O-ethylfangchinoline in mice

  2015cites this paper
• Predictive validity of the neurokinin-1 knockout mouse in research into Attention Deficit Hyperactivity Disorder

  2015cites this paper
• The benefit of combined acupuncture and antidepressant medication for depression: A systematic review and meta-analysis.

  2015cites this paper
• EVALUATION OF ANTIDEPRESSANT ACTIVITY OF ETHANOL AND CHLOROFORM EXTRACTS OF ANTIGONON LEPTOPUS

  2015cites this paper
• Development of potent dopamine-norepinephrine uptake inhibitors (DNRIs) based on a (2S,4R,5R)-2-benzhydryl-5-((4-methoxybenzyl)amino)tetrahydro-2H-pyran-4-ol molecular template.

  2015cites this paper
• Evaluation of the antidepressant activity of Moringa oleifera alone and in combination with fluoxetine

  2015cites this paper
• Nonmotor Symptoms in Dopa‐Responsive Dystonia

  2015cites this paper
• Antidepressant Effect ofBrassica nigra Seeds in Swiss Mice Using Tail Suspension Test

  2015cites this paper
• Hyperhomocysteinemia and DNA hypomethylation leading to reduced monoamines synthesis in depression: A case-control study

  2015cites this paper
• Antidepressant-like activity of dehydrozingerone: involvement of the serotonergic and noradrenergic systems.

  2014cites this paper
• ANTIDEPRESSANT EFFECTS: HYDROALCOHOLIC EXTRACT OF WITHANIA SOMNIFERA, BERBERIS ARISTATA AND MUCUNA PRURIENS ON TAIL SUSPENSION TEST IN MICE

  2014cites this paper
• Increased α2- and β1-adrenoceptor densities in postmortem brain of subjects with depression: differential effect of antidepressant treatment.

  2014cites this paper
• Depressive-like behavior induced by tumor necrosis factor-α is abolished by agmatine administration.

  2014cites this paper
• Antidepressant-like effect of the hydroethanolic leaf extract of Alchornea cordifolia (Schumach. & Thonn.) Mull. Arg. (Euphorbiaceae) in mice: involvement of monoaminergic system.

  2014cites this paper
• The extinction of drugs for clinical research: Can the ECNP medicines chest save them?

  2014cites this paper
• Low baseline salivary 3-methoxy-4-hydroxyphenylglycol (MHPG) in drug-naïve patients with short-illness-duration first episode major depressive disorder.

  2014cites this paper
• Venlafaxine, paroxetine and milnacipran for major depressive disorder: a pragmatic 24-week study.

  2014cites this paper
• Potential of novel phytoecdysteroids isolated from Vitex doniana in the treatment depression: involvement of monoaminergic systems.

  2014cites this paper
• Effects of Acute and Sustained Administration of Vilazodone (EMD68843) on Monoaminergic Systems: An In Vivo Electrophysiological Study

  2014cites this paper
• Norepinephrine transporter occupancy by nortriptyline in patients with depression: a positron emission tomography study with (S,S)-[¹⁸F]FMeNER-D₂.

  2014cites this paper
• Evaluation of Antidepressant Activity of Ethanolic Extract of Dacus Carota in Mice

  2014cites this paper
• Acupuncture/electroacupuncture enhances anti-depressant effect of Seroxat: the Symptom Checklist-90 scores

  2014cites this paper
• An Investigation of Anti-Depressant Activity of Cinnamomum Camphora Oil in Experimental Mice

  2013cites this paper
• The activation of α1-adrenoceptors is implicated in the antidepressant-like effect of creatine in the tail suspension test.

  2013cites this paper
• Kinetic modeling and occupancy measures of the norepinephrine transporters in baboons using single photon emission computed tomography with 123I‐INER

  2013cites this paper
• Differenzialindikation von Antidepressiva

  2013cites this paper
• CENTRO DE CIÊNCIAS BIOLÓGICAS Programa de Pós-Graduação em Bioquímica

  2013cites this paper
• Emotion and decision-making explained: a précis.

  2013cites this paper
• Quetiapine and Norquetiapine Serum Concentrations and Clinical Effects in Depressed Patients Under Augmentation Therapy With Quetiapine

  2013cites this paper
• 5-HT2A receptor inactivation potentiates the acute antidepressant-like activity of escitalopram: involvement of the noradrenergic system

  2013cites this paper
• Evaluation of the Effects of Duloxetine and Escitalopram on 24-Hour Heart Rate Variability: A Mechanistic Study Using Heart Rate Variability as a Pharmacodynamic Measure

  2013cites this paper
• [Individualized treatment with antidepressants].

  2013cites this paper
• The antidepressant-like effect of bacopaside I: possible involvement of the oxidative stress system and the noradrenergic system.

  2013cites this paper
• Uliginosin B, a phloroglucinol derivative from Hypericum polyanthemum: a promising new molecular pattern for the development of antidepressant drugs.

  2012cites this paper
• INVESTIGAÇÃO DO POTENCIAL ANTIDEPRESSIVO DE ROSMARINUS OFFICINALIS

  2012cites this paper
• CENTRO DE CIÊNCIAS BIOLÓGICAS DEPARTAMENTO DE FARMACOLOGIA PROGRAMA DE PÓS-GRADUAÇÃO EM FARMACOLOGIA ESTUDOS DA ESTRUTURA COMPORTAMENTAL DE CAMUNDONGOS NOS TESTES DE NADO FORÇADO E DA SUSPENSÃO PELA CAUDA.

  2012cites this paper
• Antidepressant-like effect of Valeriana glechomifolia Meyer (Valerianaceae) in mice.

  2012cites this paper
• The antidepressant-like effect of Hedyosmum brasiliense and its sesquiterpene lactone, podoandin in mice: evidence for the involvement of adrenergic, dopaminergic and serotonergic systems.

  2012cites this paper
• Antidepressant-like effects of the extract from Cimicifuga foetida L.

  2012cites this paper